Sean J. Pittock

Neurology

200 1st St SW
Rochester, MN 55905

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 429 publications

Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results.

Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 13, 2026

TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results.

TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 13, 2026

Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Journal: JAMA neurology

Published: July 13, 2026

IL-6 Receptor Blockade as Rescue Therapy in Acute Attacks of MOGAD and AQP4+NMOSD.

IL-6 Receptor Blockade as Rescue Therapy in Acute Attacks of MOGAD and AQP4+NMOSD.

Journal: JAMA neurology

Published: June 15, 2026

Clinical course of critical demyelinating lesion-associated progressive multiple sclerosis.

Clinical course of critical demyelinating lesion-associated progressive multiple sclerosis.

Journal: Journal of neurology

Published: April 21, 2026

Analysis of MOG-IgG and AQP4-IgG Serology, Demographics, and Seasonality From Large Neuroimmunology Laboratory Registry and Clinical Cohorts.

Analysis of MOG-IgG and AQP4-IgG Serology, Demographics, and Seasonality From Large Neuroimmunology Laboratory Registry and Clinical Cohorts.

Journal: Neurology open access

Published: April 20, 2026

TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results.

TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: April 01, 2026

Aquaporin-4's dynamic expression and biological variations within the tumor obscure the paraneoplastic phenomenon in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder.

Aquaporin-4's dynamic expression and biological variations within the tumor obscure the paraneoplastic phenomenon in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder.

Journal: Acta neuropathologica

Published: March 20, 2026

OCT-defined optic atrophy thresholds are associated with blunted optic nerve swelling in recurrent optic neuritis.

OCT-defined optic atrophy thresholds are associated with blunted optic nerve swelling in recurrent optic neuritis.

Journal: Multiple sclerosis and related disorders

Published: March 15, 2026

Genetic screening for CSF1R variants in patients with dementia, parkinsonism, and multiple sclerosis.

Genetic screening for CSF1R variants in patients with dementia, parkinsonism, and multiple sclerosis.

Journal: Neurologia i neurochirurgia polska

Published: March 08, 2026

Safety and efficacy of ravulizumab in patients with NMOSD previously treated with rituximab: A post hoc analysis of the CHAMPION-NMOSD trial.

Safety and efficacy of ravulizumab in patients with NMOSD previously treated with rituximab: A post hoc analysis of the CHAMPION-NMOSD trial.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: March 05, 2026

Gephyrin Neurological Autoimmunity.

Gephyrin Neurological Autoimmunity.

Journal: Annals of neurology

Published: February 20, 2026

Showing 1-12 of 429

Last Updated: 09/26/2026